Joel Cohen, MD

AboutSkin Dermatology and DermSurgery
Englewood, CO
USA 80113
Papers:
Long-Term Safety of Abobotulinumtoxin A for the Treatment of Glabellar Lines From a 36-Month, Multicenter, Open-Label Extension Study